Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide
Oncoscience · 01.04.2026 · 132026 · 120
DOI: 10.18632/oncoscience.654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncoscience, online erschienen am 01.04.2026. Verfasst von Joseph A Bauer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nitric Oxide Services, LLC, Akron, OH 44312, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nitric Oxide Services, LLC, Akron, OH 44312, USA.
- Cleveland Clinic Foundation, Taussig Cancer Center, Translational Hematology and Oncology Research, Cleveland, OH 44195, USA.
- Bauer Research Foundation, Inc., Akron, OH 44312, USA.
- Division of Mathematics and Sciences, Walsh University, North Canton, OH 44720, USA.
Zitieren
APA
Bauer, J. A., Sysel, A. M., & Dunphy, M. J. (2026). Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide. Oncoscience, 132026(0), 120. https://doi.org/10.18632/oncoscience.654
Vancouver
Bauer JA, Sysel AM, Dunphy MJ. Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide. Oncoscience. 2026;132026(0):120. doi:10.18632/oncoscience.654
BibTeX
@article{Bauer2026,
author = {Bauer, Joseph A and Sysel, Annette M and Dunphy, Michael J},
title = {Selective blood–brain barrier penetration and tumor targeting of nitrosylcobalamin in glioblastoma: Pharmacokinetics, tissue distribution, and synergistic activity with trail and temozolomide},
journal = {Oncoscience},
year = {2026},
volume = {132026},
number = {0},
pages = {120},
doi = {10.18632/oncoscience.654}
}
EUVIMED